One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of the enzyme myeloperoxidase (MPO) in leukocytes from a clinical specimen.
| Company | Devices | Share |
|---|---|---|
| Bio Sb, Inc. | 18 | 24% |
| Cell Marque Corporation | 16 | 21% |
| Diagnostic Biosystems, Inc. | 13 | 17% |
| Agilent Technologies Singapore Pte Ltd | 7 | 9% |
| Fuzhou Maixin Biotech Co., Ltd. | 4 | 5% |
| Epitomics Inc. | 4 | 5% |
| Biocare Medical Llc | 3 | 4% |
| Biogenex Laboratories | 3 | 4% |
| Leica Biosystems Newcastle Ltd | 2 | 3% |
| Slmp, Llc | 2 | 3% |
| Becton, Dickinson And Company | 2 | 3% |
| Life Technologies Corporation | 1 | 1% |
Company = labeler of record on GUDID. 13 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| NJT | Immunohistochemistry Reagents And Kits | 59 |
| NJT | IMMUNOHISTOCHEMISTRY REAGENTS AND KITS | 10 |
| MVU | Reagents, specific, analyte | 6 |
| MVU | REAGENTS,SPECIFIC,ANALYTE | 1 |
| MVU | Reagents, Specific, Analyte | 1 |
Use these as the dimensions to specify in a tender line.
76 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Leukocyte myeloperoxidase (MPO) IVD, antibody", from 13 companies. The largest labeler is Bio Sb, Inc. with 24% of records.
NJT (Immunohistochemistry Reagents And Kits), NJT (IMMUNOHISTOCHEMISTRY REAGENTS AND KITS), MVU (Reagents, specific, analyte), MVU (REAGENTS,SPECIFIC,ANALYTE)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add leukocyte myeloperoxidase (mpo) ivd, antibody to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.